Novartis Investigative Site

Hitachi, Ibaraki 317-0077

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Atherosclerosis

Studies at this site

• Dose Finding Study for QAW039 in Asthma — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed